After correcting for the effect of sex, age, hypertension, eGFR, 24-h urinary protein quantification, and serum PLA2R positivity, the probability of non-remission in the high-grade group was 4.310 times higher than in the low-grade group (95% CI [1.537–12.089], P = 0.005). This evidence concerns the gene PLA2R1 and hypertensive disorder.